R E Morris Selected Research

R E Morris Research Topics

5	Bronchiolitis 01/2002 - 02/2000
3	Vascular Diseases (Vascular Disease) 08/2001 - 01/2000
2	Ovarian Neoplasms (Ovarian Cancer) 05/2002 - 10/2001
2	Fibrosis (Cirrhosis) 01/2002 - 05/2000
2	Neoplasms (Cancer) 10/2001 - 05/2000
1	Anemia 08/2002
1	Fever (Fevers) 09/2001
1	Anuria 09/2001
1	Hyperplasia 04/2001
1	Drug-Related Side Effects and Adverse Reactions 05/2000
1	Torticollis (Wryneck) 03/2000
1	Wounds and Injuries (Trauma) 02/2000
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2000

3	Sirolimus (Rapamycin)FDA Link 09/2000 - 01/2000
2	RutheniumIBA 05/2002 - 10/2001
2	Phenobarbital (Luminal)FDA Link 01/2002 - 06/2001
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2002
1	Cisplatin (Platino)FDA LinkGeneric 05/2002
1	isonicotinamideIBA 10/2001
1	ethylenediamine (ethylenediamine dihydroiodide)FDA Link 10/2001
1	acetonitrileIBA 10/2001
1	Benzene (Benzole)IBA 10/2001
1	CreatinineIBA 09/2001
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 04/2001
1	Immunosuppressive Agents (Immunosuppressants)IBA 04/2001
1	Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA 05/2000
1	MitogensIBA 05/2000
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2000
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 05/2000
1	AntibodiesIBA 03/2000
1	Type A Botulinum Toxins (Botox)FDA Link 03/2000
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2000

3	Lung Transplantation 06/2000 - 02/2000
2	Transplantation 01/2002 - 06/2001
1	Organ Transplantation 08/2001
1	Oral Administration 04/2001
1	Operative Surgical Procedures 02/2000
1	Therapeutics 01/2000